Validation of the HER2DX genomic test in first-line advanced HER2-positive breast cancer treated with trastuzumab, pertuzumab, and taxane. - Kubeczko M; Cobo S; Sanchez-Bayona R; Pyciński B; Soberino J; Chmielik E; Sanfeliu E; Rey M; Pardo F; Aguirre A; Castillo O; Lesniak A; et al. (NPJ breast cancer, 2026)